Guangkang Biochemical Co., Ltd.

Announcement on the Expiration and Implementation of Specific Shareholders' Share Reduction Plan

Legal Opinion on the 2025 Annual Shareholders' Meeting of Guangkang Biochemical

Announcement of the 2025 Annual Shareholders' Meeting Resolutions

Announcement on the Proposed Reappointment of the Accounting Firm

Huatai United Securities Co., Ltd. Tracking Report for Guangdong Guangkang Biochemical Technology Co., Ltd. for the Year 2025

Huatai United Securities Co., Ltd. On-Site Inspection Report for Guangdong Guangkang Biochemical Technology Co., Ltd. for the Year 2025

Huatai United Securities Co., Ltd. Special Verification Report on the Storage, Management, and Use of Raised Funds for Guangdong Guangkang Biochemical Technology Co., Ltd. for the Year 2025

Huatai United Securities Co., Ltd. Verification Opinion on the Delay of Some Investment Projects of Raised Funds for Guangdong Guangkang Biochemical Technology Co., Ltd.

Huatai United Securities Co., Ltd. Verification Opinion on Guangdong Guangkang Biochemical Technology Co., Ltd.'s Internal Control Evaluation Report for the Year 2025

Independent Director Work Report for the Year 2025 (Zhang Zhixiang)

Independent Director Work Report for the Year 2025 (Huang Zhiwei)

Independent Director Work Report for the Year 2025 (Peng Wenping)

Announcement on Holding the Online Performance Presentation for the Year 2025

Internal Control Audit Report of Guangdong Guangkang Biochemical Technology Co., Ltd. as of December 31, 2025

Internal Control Evaluation Report for the Year 2025

Shareholder Dividend Return Plan for the Next Three Years (2026-2028)

Compensation Management System for Directors and Senior Management

Board of Directors Work Report for the Year 2025

Announcement on the Application for Comprehensive Credit Line from Banks for the Year 2026

Announcement on the Salary Situation of Directors and Senior Management for 2025 and the Salary Plan for 2026

Announcement on the Delay of Some Investment Projects of Raised Funds

Notice of the 2025 Annual Shareholders' Meeting

Announcement of Resolutions from the Fifth Meeting of the Fourth Board of Directors (2025)

Announcement on the Company's Profit Distribution Plan for the Year 2025

Quarterly Report for Q1 2026

Special Report on the Storage, Management, and Use of Raised Funds for the Year 2025

Huatai United Securities Co., Ltd. Verification Opinion on Guangdong Guangkang Biochemical Technology Co., Ltd.'s Securities and Derivatives Investment for the Year 2025

Special Explanation on Securities and Derivatives Investment for the Year 2025

Annual Verification Report on the Storage, Management, and Use of Raised Funds

Company's Evaluation Report on the Performance of the Accounting Firm

Report from the Board of Directors' Audit Committee on the Supervision Responsibilities of the Accounting Firm

Special Explanation on Non-Operating Fund Occupation and Other Related Fund Transactions for the Year 2025

Summary Table of Non-Operating Fund Occupation and Other Related Fund Transactions for the Year 2025

Special Report from the Board of Directors on the Self-Examination of Independent Directors' Independence

Annual Audit Report for 2025

Annual Report for 2025

Summary of the Annual Report for 2025

Verification Opinion from Huatai United Securities Co., Ltd. on Guangdong Guangkang Biochemical Technology Co., Ltd.'s Use of Idle Self-owned Funds for Entrusted Financial Management

Announcement on Using Idle Self-owned Funds for Entrusted Financial Management

Announcement on the 'Quality Return Dual Improvement' Action Plan

Huatai United Securities Co., Ltd.'s 2025 Training Situation Report for Guangdong Guangkang Biochemical Technology Co., Ltd. during the Continuous Supervision Period

Announcement on the Completion of the Share Reduction Plan by Specific Shareholders